{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_mesalamine",
          "name": "Mesalamine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_pentasa",
          "name": "Pentasa"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_sulfasalazine",
          "name": "Sulfasalazine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_tofacitinib",
          "name": "Tofacitinib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_mercaptopurine",
          "name": "Mercaptopurine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 2
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_pentasa",
          "type": "Drug",
          "label": "Pentasa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sulfasalazine",
          "type": "Drug",
          "label": "Sulfasalazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tofacitinib",
          "type": "Drug",
          "label": "Tofacitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mercaptopurine",
          "type": "Drug",
          "label": "Mercaptopurine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tg",
          "type": "Target",
          "label": "TNF-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pb",
          "type": "Pathway",
          "label": "Inflammatory Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_gastrointestinal_barrier_disorders",
          "type": "Disease",
          "label": "Gastrointestinal epithelial barrier disorders",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_budesonide",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知对炎症反应有抑制作用"
        },
        {
          "source": "drug_mesalamine",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "同类药理作用"
        },
        {
          "source": "drug_pentasa",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于相应疾病的临床证据"
        },
        {
          "source": "drug_sulfasalazine",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于治疗肠道炎症"
        },
        {
          "source": "drug_prednisone",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "免疫抑制剂，有效于炎症"
        },
        {
          "source": "drug_infliximab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向TNF-alpha，有效抑制炎症"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向TNF-alpha，有效抑制炎症"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "作用于特定的免疫通路"
        },
        {
          "source": "drug_tofacitinib",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "口服的JAK抑制剂，有调节作用"
        },
        {
          "source": "drug_azathioprine",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "免疫抑制剂，影响炎症过程"
        },
        {
          "source": "drug_mercaptopurine",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "免疫抑制及抗炎作用"
        },
        {
          "source": "drug_vedolizumab",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "针对活化的淋巴细胞，调节炎症过程"
        },
        {
          "source": "n_tg",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "TNF-alpha 在炎症通路中起关键作用"
        },
        {
          "source": "n_pb",
          "target": "d_gastrointestinal_barrier_disorders",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路与肠道屏障疾病密切相关"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过调节炎症相关通路对肠道屏障疾病具有潜在疗效",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "上述药物具备到达相关靶器官的能力"
    ],
    "uncertainties": [
      "不同药物在临床效果和副作用方面仍需进一步验证"
    ],
    "next_focus_for_pi": [
      "是否需要进一步探索其他潜在靶点或通路？"
    ]
  }
}